Evidence map›Paper›PMID 41362560›Full record

ArticleCureus2025

Late Manifestation of Invasive Adenocarcinoma in a Right-Colon Interposition for Esophageal Atresia.

Kristina Yancey, Katherine Macmillan, Terry Jue, Kumar Sandrasegaran

Abstract readCase Reports
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Kristina YanceyRadiology, Mayo Clinic, Phoenix, USA.
Katherine MacmillanGastroenterology, Mayo Clinic, Phoenix, USA.
Terry JueGastroenterology, Mayo Clinic, Phoenix, USA.
Kumar SandrasegaranRadiology, Mayo Clinic, Phoenix, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Colonic interposition is a recognized surgical technique for esophageal replacement in patients with esophageal atresia. While generally effective, this approach carries a risk of long-term complications, including the rare development of adenocarcinoma within the interposed segment. We present the case of a 59-year-old man with a history of esophageal atresia repaired in infancy using a right-sided colonic interposition. He presented for evaluation due to worsening dysphagia and early satiety. Endoscopic examination revealed a 20 mm ulcerated lesion at the distal anastomosis, and biopsy confirmed intramucosal adenocarcinoma. Fluoroscopic esophagram and PET-CT demonstrated a mass-like lesion with focal hypermetabolism but no evidence of metastatic disease. Given significant surgical risk due to prior abdominal surgeries and poor nutritional status, the patient elected to pursue systemic immunotherapy with close imaging and endoscopic surveillance. Adenocarcinoma arising in colonic interpositions is exceedingly rare, with latency periods typically ranging from 20 to 40 years. In this case, malignancy developed nearly six decades after the initial repair. This case highlights the potential for malignant transformation many decades after esophageal reconstruction and underscores the importance of sustained clinical follow-up and endoscopic surveillance in patients with colonic interpositions.

Indexed as

colon adenocarcinomacolonic interpositionesophageal atresiaesophageal reconstructiongastrointestinal neoplasm

Identifiers

PMID41362560
PMCPMC12681438

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.